Screener
Kalaris Therapeutics KLRS Q2 2026 earnings
Reported August 11, 2026 · Before market open
EPS-$0.48Beat by $0.02
EPS estimate-$0.50
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$0.52
Versus estimates
Diluted EPS
FAQ
- When did Kalaris Therapeutics report Q2 2026 earnings?
- Kalaris Therapeutics (KLRS) reported Q2 2026 earnings on August 11, 2026 before market open.
- What were Kalaris Therapeutics's Q2 2026 revenue and EPS?
- Kalaris Therapeutics reported eps of $-0.48 for Q2 2026.
- Did Kalaris Therapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.49 by $0.02.
- How did Kalaris Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 21.3% from $-0.61.
- Where can I find Kalaris Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-343477) and the 10-Q periodic report (0001193125-26-344532) directly on SEC EDGAR. The filing index links above go to sec.gov.
